Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 23 of 23
Sensible Biotechnologies
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Sidera Bio
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2024
Hold
2yr
Signatope
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
Silk Biomaterials
Principia III - Health
Sector
Biotech
InvestorPrincipia SGR
Entry
2016
Hold
10yr
Single Technologies AB
Almi Invest (Regional funds)
Sector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
10yr
Sorriso Pharmaceuticals
Lundbeckfonden BioCapital
Sector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2021
Hold
5yr
Sortina Pharma
Eir Ventures I
Sector
Biotech
InvestorEir Ventures
Entry
2020
Hold
6yr
Souffle Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2025
Hold
1yr
Stayble Therapeutics
Chalmers Ventures
Sector
Biotech
InvestorChalmers Ventures
Entry
2016
Hold
10yr
StemTek Therapeutics
Fondo BI
Sector
Biotech
InvestorSeed Capital de Bizkaia
Entry
2016
Hold
10yr
Strand Therapeutics
Kinnevik
Sector
Biotech
InvestorKinnevik
Entry
2025
Hold
1yr
Sudo Biosciences
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
SVF Vaccines
Karolinska Development
Sector
Biotech
InvestorKarolinska Development
Entry
2020
Hold
6yr
SwitchKine
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
Syngoi Technologies
Columbus Life Sciences Fund IV
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2023
Hold
3yr
Synklino
EIFO (direct equity)
Sector
Biotech
InvestorEifo
Entry
2020
Hold
6yr
SynOx Therapeutics Ltd
HealthCap VII
Sector
Biotech
InvestorHealthCap
Entry
2020
Hold
6yr
Synthetica Pioneering
Boehringer Ingelheim Venture Fund
China
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
T-Curx
Seedfonds Bayern
Sector
Biotech
InvestorBayern Kapital
Entry
2025
Hold
1yr
T-One Therapeutics
Utopia SIS
Sector
Biotech
InvestorUtopia SIS
Entry
2022
Hold
4yr
T7 Therapeutics
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
TargED Biopharmaceuticals
Sunstone Life Science Ventures V
Sector
Biotech
InvestorSunstone Life Science Ventures
Entry
2022
Hold
4yr
Tarveda Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
TECregen
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Ternary Therapeutics
Daphni Blue
Sector
Biotech
InvestorDaphni
Entry
2025
Hold
1yr
Terremoto Biosciences
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2023
Hold
3yr
Thelior Bio
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2025
Hold
1yr
Third Harmonic Bio
General Atlantic
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
TIBEAY Biosciences
MIG Fonds 18
Sector
Biotech
InvestorMIG Capital
Entry
2026
Hold
0yr
TolemyBio
JME Ventures IV
Sector
Biotech
InvestorJME Ventures
Entry
2026
Hold
0yr
TRIM TX
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2025
Hold
1yr
Twogee Biotech
Seedfonds Bayern
Sector
Biotech
InvestorBayern Kapital
Entry
2026
Hold
0yr
Umecrine Cognition
Almi Invest (Regional funds)
Sector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
10yr
Umecrine Mood
Rosetta Capital IV
Sector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Univercells
AFB Fund II
Sector
Biotech
InvestorAdBio Partners
Entry
2022
Hold
4yr
Unshackled
CVX Ventures
Sector
Biotech
InvestorCVX Ventures
Entry
2025
Hold
1yr
Vascurie
Almi Invest (Regional funds)
Sector
Biotech
InvestorAlmi Invest
Entry
2026
Hold
0yr
Vesigen Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
6yr
Vesper Bio
Lundbeckfonden BioCapital
Sector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2012
Hold
14yr
Vespina Life Sciences, Inc.
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
Vincere Biosciences
Oscar & Paul Venture Capital Fund I
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2025
Hold
1yr
Vir
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–
Viroclinics Biosciences
Summit Partners Portfolio
Sector
Biotech
InvestorSummit Partners
Entry
2023
Hold
3yr
VoxIBio
Almi Invest (Regional funds)
Sector
Biotech
InvestorAlmi Invest
Entry
2025
Hold
1yr
Windward Bio AG
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2026
Hold
0yr
Xilis
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–
Xintela
Flerie Invest
Sector
Biotech
InvestorFlerie
Entry
2022
Hold
4yr
Yukin Therapeutics
AFB Seed-Fund
Sector
Biotech
InvestorAdBio Partners
Entry
2019
Hold
7yr
Zafrens
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Zencore Biologics
Novo Holdings Bioindustrial Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr